| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |